Patients with multiple myeloma (MM) have a distinct pattern of second primary malignancy (SPM), with a markedly increased ...
Women diagnosed with hematological malignancies during pregnancy face higher severe maternal morbidity and obstetric complications compared to post-pregnancy diagnoses. The study analyzed data from ...
Multiple myeloma accounts for only 1.8% of cancers, but it is the second-most common blood cancer, with approximately 36,000 ...
This chart illustrates the trends in ASIR and ASMR of major hematological malignancies, including HL, NHL, MM, and leukemia, across the world, China, and the United States from 1990 to 2021. Based on ...
Findings showed Orca-T statistically significantly improved survival free of moderate to severe cGvHD vs alloHSCT at 1 year. The Food and Drug Administration (FDA) has accepted for Priority Review the ...
The Food and Drug Administration (FDA) has extended the review period for Orca-T in the treatment of patients with hematologic malignancies. Orca-T is an allogeneic T-cell immunotherapy that consists ...
Table 1. Common causes and pathogenic mechanisms of acute and chronic renal impairment in patients with hematological malignancies. Category Causes and pathogenetic mechanisms Ref. Disease related ...
Fewer than 1% of all causes of ascites are attributed to conditions other than liver cirrhosis, cardiac disease or malignancy. In this case, the patient presented with massive splenomegaly and later ...
Lactic acidosis represents a challenging metabolic complication in patients with haematological malignancies. Notably, type B lactic acidosis occurs in the absence of hypoxia and is associated with ...
A research team has developed a new class of compounds that effectively inhibit both wild-type CDK9 and its drug-resistant mutant form, offering a promising strategy for treating hematological ...
Gallbladder cancer is often diagnosed late due to its asymptomatic nature in early stages, complicating treatment options. Diagnosis involves blood tests, imaging, and ERCP, with staging using the TNM ...